Clinical Trials Browser

Stage I Prostate Adenocarcinoma × pexidartinib × Clear all

NCT02472275 2020-10-06

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Phase 1 Completed

Stage I Prostate Adenocarcinoma